Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers
Karoline Kuchenbaecker(University of Cambridge), M. Durán(Universidad de Valladolid), Paul A. James(The Royal Melbourne Hospital), Banu Arun(The University of Texas Health Science Center at Houston), Thomas van Overeem Hansen(University of Copenhagen), Christoph Engel(University Hospital Leipzig), Bent Ejlertsen, Ana Osório(Spanish National Cancer Research Centre), Daniel Barrowdale(University of Cambridge), Robert L. Nussbaum(National Institutes of Health), Mark E. Robson(Memorial Sloan Kettering Cancer Center), Susan J. Ramus(Cancer Institute of New South Wales), Joe Dennis(University of Cambridge), Irene L. Andrulis(University of Toronto), Anna Marie Mulligan, Heli Nevanlinna(University of Helsinki), Ramūnas Janavičius(Vilnius University), Susan L. Neuhausen(City of Hope), Mary Beth Terry(Columbia University Irving Medical Center), Susan M. Domchek(University City Science Center), Susan L. Slager(Mayo Clinic), Katherine L. Nathanson(Translational Therapeutics (United States)), Linda Steele(University of Technology Sydney), Saundra S. Buys(University of Utah), Breast Cancer Family Registry(Cancer Prevention Institute of California), Anne‐Marie Gerdes(Copenhagen University Hospital), Beth Y. Karlan(University of California, Los Angeles), Steven N. Hart(Cornell University), Melissa C. Southey(The University of Melbourne), Andrew Lee(University of Cambridge), Ilana Cass(Cedars-Sinai Medical Center), Mary B Daly(Fox Chase Cancer Center), Cecilia M. Dorfling(QIMR Berghofer Medical Research Institute), Barbara Wappenschmidt(University Hospital Cologne), Laima Tihomirova(Latvian Biomedical Research and Study Centre), Julie Cunningham(Mayo Clinic in Arizona), Amanda B. Spurdle(QIMR Berghofer Medical Research Institute), Paolo Radice(IFOM), Lesley McGuffog(University of Cambridge), David E. Goldgar(University of Utah), Finn C. Nielsen(Copenhagen University Hospital), Jenny Lester(Cedars-Sinai Medical Center), Sue Healey(QIMR Berghofer Medical Research Institute), Timothy R. Rebbeck(University of Pennsylvania), Mads Thomassen(Odense University Hospital), Javier Benítez(Spanish National Cancer Research Centre), Rita K. Schmutzler(The University of Melbourne), Marjanka K. Schmidt(University of Cambridge), Nadine Tung(Beth Israel Deaconess Medical Center), Elizabeth J. van Rensburg(University of Pretoria)
Cited by 69
Related Papers
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Mortality Results from a Randomized Prostate-Cancer Screening Trial
|New England Journal of Medicine|2009|2.9k